

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 8.00879142 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 7.80684613 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.58142765 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.58142765 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.26533903 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.26533903 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.81996630 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.15320972 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.14360284 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.14360284 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.14360284 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.99458981 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.89756375 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.85544986 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.79341534 |
| 16 | regulation of plasminogen activation (GO:0010755) | 5.64926862 |
| 17 | urea metabolic process (GO:0019627) | 5.59844566 |
| 18 | urea cycle (GO:0000050) | 5.59844566 |
| 19 | cysteine metabolic process (GO:0006534) | 5.56474251 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.53940144 |
| 21 | drug metabolic process (GO:0017144) | 5.52978759 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 5.46821117 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.42656367 |
| 24 | oxidative demethylation (GO:0070989) | 5.42643461 |
| 25 | high-density lipoprotein particle remodeling (GO:0034375) | 5.39227259 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.24638899 |
| 27 | protein carboxylation (GO:0018214) | 5.24638899 |
| 28 | regulation of fibrinolysis (GO:0051917) | 5.23843380 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 5.15492527 |
| 30 | complement activation, alternative pathway (GO:0006957) | 5.12457768 |
| 31 | regulation of protein activation cascade (GO:2000257) | 5.10219243 |
| 32 | bile acid metabolic process (GO:0008206) | 5.00182591 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.99014008 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 4.97104236 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.92318231 |
| 36 | ethanol metabolic process (GO:0006067) | 4.91117589 |
| 37 | lysine catabolic process (GO:0006554) | 4.90161480 |
| 38 | lysine metabolic process (GO:0006553) | 4.90161480 |
| 39 | * serine family amino acid catabolic process (GO:0009071) | 4.89609774 |
| 40 | intestinal cholesterol absorption (GO:0030299) | 4.84188818 |
| 41 | tyrosine metabolic process (GO:0006570) | 4.79060803 |
| 42 | regulation of complement activation (GO:0030449) | 4.76602969 |
| 43 | phenylpropanoid metabolic process (GO:0009698) | 4.74835544 |
| 44 | reverse cholesterol transport (GO:0043691) | 4.73215903 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 4.71327400 |
| 46 | regulation of cholesterol esterification (GO:0010872) | 4.70454364 |
| 47 | regulation of triglyceride catabolic process (GO:0010896) | 4.66428062 |
| 48 | * alpha-amino acid catabolic process (GO:1901606) | 4.66389557 |
| 49 | protein-lipid complex remodeling (GO:0034368) | 4.63530642 |
| 50 | macromolecular complex remodeling (GO:0034367) | 4.63530642 |
| 51 | plasma lipoprotein particle remodeling (GO:0034369) | 4.63530642 |
| 52 | negative regulation of blood coagulation (GO:0030195) | 4.53361216 |
| 53 | negative regulation of hemostasis (GO:1900047) | 4.53361216 |
| 54 | cellular ketone body metabolic process (GO:0046950) | 4.51907217 |
| 55 | S-adenosylmethionine metabolic process (GO:0046500) | 4.51727009 |
| 56 | triglyceride homeostasis (GO:0070328) | 4.49625928 |
| 57 | acylglycerol homeostasis (GO:0055090) | 4.49625928 |
| 58 | regulation of humoral immune response (GO:0002920) | 4.48835395 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.48489961 |
| 60 | negative regulation of sterol transport (GO:0032372) | 4.48489961 |
| 61 | acute-phase response (GO:0006953) | 4.47101500 |
| 62 | negative regulation of protein activation cascade (GO:2000258) | 4.44850787 |
| 63 | phospholipid efflux (GO:0033700) | 4.38954086 |
| 64 | coenzyme catabolic process (GO:0009109) | 4.37004294 |
| 65 | indolalkylamine metabolic process (GO:0006586) | 4.34757605 |
| 66 | glutamate metabolic process (GO:0006536) | 4.32895189 |
| 67 | * cellular amino acid catabolic process (GO:0009063) | 4.32746066 |
| 68 | plasma lipoprotein particle clearance (GO:0034381) | 4.30063359 |
| 69 | bile acid and bile salt transport (GO:0015721) | 4.28806396 |
| 70 | cellular modified amino acid catabolic process (GO:0042219) | 4.26959277 |
| 71 | cellular biogenic amine catabolic process (GO:0042402) | 4.25416208 |
| 72 | amine catabolic process (GO:0009310) | 4.25416208 |
| 73 | cellular glucuronidation (GO:0052695) | 4.22925606 |
| 74 | imidazole-containing compound metabolic process (GO:0052803) | 4.22635176 |
| 75 | cytolysis (GO:0019835) | 4.17376908 |
| 76 | serine family amino acid biosynthetic process (GO:0009070) | 4.15735026 |
| 77 | * serine family amino acid metabolic process (GO:0009069) | 4.13842929 |
| 78 | benzene-containing compound metabolic process (GO:0042537) | 4.12472906 |
| 79 | opsonization (GO:0008228) | 4.12213104 |
| 80 | negative regulation of coagulation (GO:0050819) | 4.11442517 |
| 81 | * glycine metabolic process (GO:0006544) | 4.11118909 |
| 82 | drug catabolic process (GO:0042737) | 4.09407355 |
| 83 | ethanol oxidation (GO:0006069) | 4.08836091 |
| 84 | plasma lipoprotein particle organization (GO:0071827) | 4.06058469 |
| 85 | positive regulation of hemostasis (GO:1900048) | 4.05807879 |
| 86 | positive regulation of blood coagulation (GO:0030194) | 4.05807879 |
| 87 | cholesterol efflux (GO:0033344) | 4.05258369 |
| 88 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.05173790 |
| 89 | negative regulation of wound healing (GO:0061045) | 4.01410315 |
| 90 | arginine metabolic process (GO:0006525) | 4.00029385 |
| 91 | aldehyde catabolic process (GO:0046185) | 3.93997994 |
| 92 | ketone body metabolic process (GO:1902224) | 3.92907879 |
| 93 | low-density lipoprotein particle remodeling (GO:0034374) | 3.91286052 |
| 94 | fibrinolysis (GO:0042730) | 3.90939987 |
| 95 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.90241610 |
| 96 | plasma lipoprotein particle assembly (GO:0034377) | 3.87023653 |
| 97 | short-chain fatty acid metabolic process (GO:0046459) | 3.86805831 |
| 98 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.85219824 |
| 99 | * carboxylic acid catabolic process (GO:0046395) | 3.79619468 |
| 100 | * organic acid catabolic process (GO:0016054) | 3.79619468 |
| 101 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.79163025 |
| 102 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.79163025 |
| 103 | uronic acid metabolic process (GO:0006063) | 3.77516048 |
| 104 | glucuronate metabolic process (GO:0019585) | 3.77516048 |
| 105 | protein-lipid complex subunit organization (GO:0071825) | 3.75490750 |
| 106 | acetyl-CoA metabolic process (GO:0006084) | 3.75289524 |
| 107 | cofactor catabolic process (GO:0051187) | 3.72313907 |
| 108 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71619318 |
| 109 | alkaloid metabolic process (GO:0009820) | 3.70969249 |
| 110 | regulation of cholesterol homeostasis (GO:2000188) | 3.69577505 |
| 111 | positive regulation of coagulation (GO:0050820) | 3.68780497 |
| 112 | phospholipid homeostasis (GO:0055091) | 3.68754182 |
| 113 | cholesterol homeostasis (GO:0042632) | 3.68545278 |
| 114 | regulation of apoptotic cell clearance (GO:2000425) | 3.67593912 |
| 115 | blood coagulation, intrinsic pathway (GO:0007597) | 3.67547177 |
| 116 | aspartate family amino acid catabolic process (GO:0009068) | 3.67212724 |
| 117 | positive regulation of lipid catabolic process (GO:0050996) | 3.66764276 |
| 118 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.66762966 |
| 119 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.66762966 |
| 120 | urate metabolic process (GO:0046415) | 3.65437888 |
| 121 | negative regulation of complement activation (GO:0045916) | 3.64440813 |
| 122 | drug transmembrane transport (GO:0006855) | 3.63878915 |
| 123 | sterol homeostasis (GO:0055092) | 3.63260330 |
| 124 | negative regulation of lipase activity (GO:0060192) | 3.61905269 |
| 125 | exogenous drug catabolic process (GO:0042738) | 3.60082362 |
| 126 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.59996436 |
| 127 | complement activation, classical pathway (GO:0006958) | 3.57555336 |
| 128 | 2-oxoglutarate metabolic process (GO:0006103) | 3.57325591 |
| 129 | complement activation (GO:0006956) | 3.55800939 |
| 130 | protein activation cascade (GO:0072376) | 3.54395326 |
| 131 | peptidyl-glutamic acid modification (GO:0018200) | 3.38520811 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.35177254 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.17737499 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.77213772 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.47176303 |
| 5 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.13003292 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.01349790 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.95694034 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.01503655 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.88678433 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.10445047 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.10228277 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8758487 |
| 13 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98963178 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.69320198 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.68892940 |
| 16 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64223651 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.44871341 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42857487 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 1.33195365 |
| 20 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.32852459 |
| 21 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.28570737 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26799439 |
| 23 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.21900319 |
| 24 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21603750 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21505346 |
| 26 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.17806683 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15088257 |
| 28 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.05281667 |
| 29 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04738832 |
| 30 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.04161274 |
| 31 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.03457264 |
| 32 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02885528 |
| 33 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.02774734 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.00382769 |
| 35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97858531 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97854276 |
| 37 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.96911214 |
| 38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.96328413 |
| 39 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.95819850 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94733507 |
| 41 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.91408670 |
| 42 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.90290508 |
| 43 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.89798676 |
| 44 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.89034145 |
| 45 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.88568068 |
| 46 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.88444094 |
| 47 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.87789491 |
| 48 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.87087214 |
| 49 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86653121 |
| 50 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.84625832 |
| 51 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82850710 |
| 52 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.81822464 |
| 53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81130030 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.80777201 |
| 55 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.80620824 |
| 56 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.80282207 |
| 57 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79250779 |
| 58 | NCOR_22424771_ChIP-Seq_293T_Human | 0.78884608 |
| 59 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.78583227 |
| 60 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78549511 |
| 61 | ERA_21632823_ChIP-Seq_H3396_Human | 0.77945629 |
| 62 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.77213204 |
| 63 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.77213204 |
| 64 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77146229 |
| 65 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.77080726 |
| 66 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.76687436 |
| 67 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.76524393 |
| 68 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.75594325 |
| 69 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72524019 |
| 70 | VDR_22108803_ChIP-Seq_LS180_Human | 0.71635757 |
| 71 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71593879 |
| 72 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71185910 |
| 73 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.70805756 |
| 74 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.70378156 |
| 75 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.70195390 |
| 76 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.69897069 |
| 77 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.69897069 |
| 78 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69608831 |
| 79 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.69052921 |
| 80 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.68815456 |
| 81 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.67979572 |
| 82 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.67707214 |
| 83 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.67585590 |
| 84 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.67434730 |
| 85 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66813924 |
| 86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66813924 |
| 87 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.66527728 |
| 88 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65396062 |
| 89 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.64786175 |
| 90 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63887993 |
| 91 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.63803428 |
| 92 | P300_27268052_Chip-Seq_Bcells_Human | 0.63538968 |
| 93 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.63433833 |
| 94 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.63128646 |
| 95 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.63062128 |
| 96 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.63035717 |
| 97 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.62476599 |
| 98 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62064403 |
| 99 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61362900 |
| 100 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.61341461 |
| 101 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.60528184 |
| 102 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.60248739 |
| 103 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.60050468 |
| 104 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.59534759 |
| 105 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.58730283 |
| 106 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58259972 |
| 107 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.58165226 |
| 108 | * ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.57430663 |
| 109 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.57280515 |
| 110 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.56462826 |
| 111 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.56445498 |
| 112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.56255619 |
| 113 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53882384 |
| 114 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53724535 |
| 115 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51742734 |
| 116 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.51639926 |
| 117 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51496406 |
| 118 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.50855027 |
| 119 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.50824191 |
| 120 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49573095 |
| 121 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.49279183 |
| 122 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.49004479 |
| 123 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48767049 |
| 124 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48649602 |
| 125 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.47231338 |
| 126 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46650222 |
| 127 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46528524 |
| 128 | GATA1_19941826_ChIP-Seq_K562_Human | 0.45381417 |
| 129 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.44958697 |
| 130 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43934042 |
| 131 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.43760857 |
| 132 | * STAT1_17558387_ChIP-Seq_HELA_Human | 0.43714993 |
| 133 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.43540023 |
| 134 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.43416632 |
| 135 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43166012 |
| 136 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42827118 |
| 137 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42285989 |
| 138 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.42094795 |
| 139 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.41013994 |
| 140 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40241746 |
| 141 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.38622547 |
| 142 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38307312 |
| 143 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.37871161 |
| 144 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.37730937 |
| 145 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.36731259 |
| 146 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.36517873 |
| 147 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.35794099 |
| 148 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.35662295 |
| 149 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.35472358 |
| 150 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.34931573 |
| 151 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.34790973 |
| 152 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.34565251 |
| 153 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.34563526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.24059217 |
| 2 | MP0005360_urolithiasis | 7.65074129 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.32577014 |
| 4 | MP0005365_abnormal_bile_salt | 6.14735905 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.08257600 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.08427764 |
| 7 | MP0003252_abnormal_bile_duct | 3.89003686 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.52215786 |
| 9 | MP0009840_abnormal_foam_cell | 3.17043603 |
| 10 | MP0005083_abnormal_biliary_tract | 3.12858919 |
| 11 | MP0005332_abnormal_amino_acid | 2.95072909 |
| 12 | MP0003195_calcinosis | 2.91523315 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.65763802 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.30153087 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.26457015 |
| 16 | MP0000609_abnormal_liver_physiology | 2.12502694 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.09722152 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.04032123 |
| 19 | MP0003868_abnormal_feces_composition | 1.90948690 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.84015466 |
| 21 | MP0001764_abnormal_homeostasis | 1.65202142 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58556923 |
| 23 | MP0005451_abnormal_body_composition | 1.49256782 |
| 24 | MP0009697_abnormal_copulation | 1.44466421 |
| 25 | MP0009643_abnormal_urine_homeostasis | 1.39368695 |
| 26 | MP0003011_delayed_dark_adaptation | 1.31832432 |
| 27 | MP0003186_abnormal_redox_activity | 1.31271881 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.30363864 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.20605078 |
| 30 | MP0003122_maternal_imprinting | 1.20419467 |
| 31 | MP0002132_abnormal_respiratory_system | 1.20136421 |
| 32 | MP0000598_abnormal_liver_morphology | 1.17230761 |
| 33 | MP0005647_abnormal_sex_gland | 1.10068529 |
| 34 | MP0006292_abnormal_olfactory_placode | 1.09513305 |
| 35 | MP0000604_amyloidosis | 1.04453499 |
| 36 | MP0005636_abnormal_mineral_homeostasis | 1.03273347 |
| 37 | MP0009764_decreased_sensitivity_to | 1.02463749 |
| 38 | MP0002254_reproductive_system_inflammat | 0.99909489 |
| 39 | MP0009763_increased_sensitivity_to | 0.97052915 |
| 40 | MP0010368_abnormal_lymphatic_system | 0.90869081 |
| 41 | MP0005670_abnormal_white_adipose | 0.89269466 |
| 42 | MP0003172_abnormal_lysosome_physiology | 0.87910557 |
| 43 | MP0005408_hypopigmentation | 0.87091146 |
| 44 | MP0009642_abnormal_blood_homeostasis | 0.87070580 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 0.86324956 |
| 46 | MP0008469_abnormal_protein_level | 0.85687499 |
| 47 | MP0002282_abnormal_trachea_morphology | 0.85245507 |
| 48 | MP0006036_abnormal_mitochondrial_physio | 0.84111282 |
| 49 | MP0005220_abnormal_exocrine_pancreas | 0.82572454 |
| 50 | MP0002876_abnormal_thyroid_physiology | 0.79422787 |
| 51 | MP0002078_abnormal_glucose_homeostasis | 0.78426226 |
| 52 | MP0005376_homeostasis/metabolism_phenot | 0.76930417 |
| 53 | MP0001915_intracranial_hemorrhage | 0.76616948 |
| 54 | MP0005379_endocrine/exocrine_gland_phen | 0.76574767 |
| 55 | MP0009765_abnormal_xenobiotic_induced | 0.75218054 |
| 56 | MP0001756_abnormal_urination | 0.74575359 |
| 57 | MP0004130_abnormal_muscle_cell | 0.73085080 |
| 58 | MP0002971_abnormal_brown_adipose | 0.72665936 |
| 59 | MP0001661_extended_life_span | 0.71940251 |
| 60 | MP0005535_abnormal_body_temperature | 0.69666605 |
| 61 | MP0005334_abnormal_fat_pad | 0.68170149 |
| 62 | MP0003879_abnormal_hair_cell | 0.67252933 |
| 63 | MP0003690_abnormal_glial_cell | 0.66553221 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 0.65924494 |
| 65 | MP0000566_synostosis | 0.65422077 |
| 66 | MP0003329_amyloid_beta_deposits | 0.65367328 |
| 67 | MP0009053_abnormal_anal_canal | 0.64058284 |
| 68 | MP0005266_abnormal_metabolism | 0.60326982 |
| 69 | MP0005646_abnormal_pituitary_gland | 0.59366766 |
| 70 | MP0002136_abnormal_kidney_physiology | 0.57356916 |
| 71 | MP0000639_abnormal_adrenal_gland | 0.55917540 |
| 72 | MP0005448_abnormal_energy_balance | 0.55483688 |
| 73 | MP0006035_abnormal_mitochondrial_morpho | 0.54901658 |
| 74 | MP0005377_hearing/vestibular/ear_phenot | 0.53631259 |
| 75 | MP0003878_abnormal_ear_physiology | 0.53631259 |
| 76 | MP0002249_abnormal_larynx_morphology | 0.53328540 |
| 77 | MP0005395_other_phenotype | 0.50588829 |
| 78 | MP0002089_abnormal_postnatal_growth/wei | 0.50124206 |
| 79 | MP0002928_abnormal_bile_duct | 0.50113869 |
| 80 | MP0003638_abnormal_response/metabolism_ | 0.49575210 |
| 81 | MP0001944_abnormal_pancreas_morphology | 0.46958323 |
| 82 | MP0005666_abnormal_adipose_tissue | 0.46680251 |
| 83 | MP0005464_abnormal_platelet_physiology | 0.45476935 |
| 84 | MP0008874_decreased_physiological_sensi | 0.43010571 |
| 85 | MP0002837_dystrophic_cardiac_calcinosis | 0.42540829 |
| 86 | MP0003718_maternal_effect | 0.42351823 |
| 87 | MP0003953_abnormal_hormone_level | 0.41990237 |
| 88 | MP0005187_abnormal_penis_morphology | 0.41531462 |
| 89 | MP0004043_abnormal_pH_regulation | 0.41377493 |
| 90 | MP0008873_increased_physiological_sensi | 0.40399182 |
| 91 | MP0002822_catalepsy | 0.40113534 |
| 92 | MP0003075_altered_response_to | 0.39978242 |
| 93 | MP0004782_abnormal_surfactant_physiolog | 0.39582346 |
| 94 | MP0004133_heterotaxia | 0.39167261 |
| 95 | MP0002090_abnormal_vision | 0.38880980 |
| 96 | MP0009672_abnormal_birth_weight | 0.38629965 |
| 97 | MP0002168_other_aberrant_phenotype | 0.38398816 |
| 98 | MP0009384_cardiac_valve_regurgitation | 0.38254263 |
| 99 | MP0003724_increased_susceptibility_to | 0.37747640 |
| 100 | MP0005248_abnormal_Harderian_gland | 0.37517657 |
| 101 | MP0000230_abnormal_systemic_arterial | 0.36867746 |
| 102 | MP0002796_impaired_skin_barrier | 0.35816568 |
| 103 | MP0008872_abnormal_physiological_respon | 0.35595648 |
| 104 | MP0005166_decreased_susceptibility_to | 0.34593583 |
| 105 | MP0005410_abnormal_fertilization | 0.34482115 |
| 106 | MP0009115_abnormal_fat_cell | 0.34160140 |
| 107 | MP0005058_abnormal_lysosome_morphology | 0.33909973 |
| 108 | MP0003436_decreased_susceptibility_to | 0.33875554 |
| 109 | MP0003123_paternal_imprinting | 0.32460639 |
| 110 | MP0001765_abnormal_ion_homeostasis | 0.31578452 |
| 111 | MP0001243_abnormal_dermal_layer | 0.31520729 |
| 112 | MP0001324_abnormal_eye_pigmentation | 0.31502008 |
| 113 | MP0001986_abnormal_taste_sensitivity | 0.31395109 |
| 114 | MP0003943_abnormal_hepatobiliary_system | 0.30880999 |
| 115 | MP0002970_abnormal_white_adipose | 0.30740783 |
| 116 | MP0000579_abnormal_nail_morphology | 0.30630022 |
| 117 | MP0002909_abnormal_adrenal_gland | 0.30502916 |
| 118 | MP0000249_abnormal_blood_vessel | 0.30466072 |
| 119 | MP0004142_abnormal_muscle_tone | 0.30424066 |
| 120 | MP0003699_abnormal_female_reproductive | 0.29439157 |
| 121 | MP0004381_abnormal_hair_follicle | 0.29382968 |
| 122 | MP0002163_abnormal_gland_morphology | 0.28982063 |
| 123 | MP0004883_abnormal_blood_vessel | 0.28749970 |
| 124 | MP0002135_abnormal_kidney_morphology | 0.27188903 |
| 125 | MP0001881_abnormal_mammary_gland | 0.26869080 |
| 126 | MP0002060_abnormal_skin_morphology | 0.26692088 |
| 127 | MP0001853_heart_inflammation | 0.25621100 |
| 128 | MP0001845_abnormal_inflammatory_respons | 0.25359875 |
| 129 | MP0003646_muscle_fatigue | 0.25153246 |
| 130 | MP0001984_abnormal_olfaction | 0.24047556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.33428139 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.22727548 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.08627112 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.53635647 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.26404163 |
| 6 | Xanthomatosis (HP:0000991) | 6.23348045 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.15432633 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.40612620 |
| 9 | Complement deficiency (HP:0004431) | 5.08409211 |
| 10 | Hyperammonemia (HP:0001987) | 4.68931062 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.65439221 |
| 12 | Joint hemorrhage (HP:0005261) | 4.64377850 |
| 13 | Hyperglycinemia (HP:0002154) | 4.58686310 |
| 14 | Ketosis (HP:0001946) | 4.42708582 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.41452111 |
| 16 | Epidermoid cyst (HP:0200040) | 4.38980306 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.31923821 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.28902984 |
| 19 | Hyperglycinuria (HP:0003108) | 4.26192833 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.25245972 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.22091828 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.21682534 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 4.18797189 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.18797189 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 4.10959305 |
| 26 | Fat malabsorption (HP:0002630) | 4.04689253 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.83738092 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.76911346 |
| 29 | Abnormality of complement system (HP:0005339) | 3.69401272 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.67380577 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.57116216 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.50785917 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.46250820 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.35290933 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.27801838 |
| 36 | Nephritis (HP:0000123) | 3.27642052 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.22060871 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.21894956 |
| 39 | Ketoacidosis (HP:0001993) | 3.21751261 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.13724252 |
| 41 | Steatorrhea (HP:0002570) | 3.04818795 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 3.01539527 |
| 43 | Gout (HP:0001997) | 2.95931705 |
| 44 | Abnormality of purine metabolism (HP:0004352) | 2.94386761 |
| 45 | Myocardial infarction (HP:0001658) | 2.91213929 |
| 46 | Metabolic acidosis (HP:0001942) | 2.84821177 |
| 47 | Hypochromic microcytic anemia (HP:0004840) | 2.79768450 |
| 48 | Spontaneous abortion (HP:0005268) | 2.79262915 |
| 49 | Skin nodule (HP:0200036) | 2.74075752 |
| 50 | Vascular calcification (HP:0004934) | 2.71566763 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.69379948 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.69379948 |
| 53 | Lethargy (HP:0001254) | 2.67542258 |
| 54 | Fair hair (HP:0002286) | 2.65833237 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.61140499 |
| 56 | Spastic diplegia (HP:0001264) | 2.51636500 |
| 57 | Purpura (HP:0000979) | 2.48991361 |
| 58 | Acanthocytosis (HP:0001927) | 2.45727778 |
| 59 | Cardiovascular calcification (HP:0011915) | 2.43488670 |
| 60 | Cerebral edema (HP:0002181) | 2.42836246 |
| 61 | Hypoglycemic seizures (HP:0002173) | 2.40445989 |
| 62 | Mitral stenosis (HP:0001718) | 2.40280856 |
| 63 | Irritability (HP:0000737) | 2.39906002 |
| 64 | Neonatal onset (HP:0003623) | 2.38888478 |
| 65 | Abnormal gallbladder morphology (HP:0012437) | 2.38441985 |
| 66 | Osteomalacia (HP:0002749) | 2.35874980 |
| 67 | Glomerulonephritis (HP:0000099) | 2.35288746 |
| 68 | Cholelithiasis (HP:0001081) | 2.33372977 |
| 69 | Malnutrition (HP:0004395) | 2.32834326 |
| 70 | Bile duct proliferation (HP:0001408) | 2.32816948 |
| 71 | Abnormal biliary tract physiology (HP:0012439) | 2.32816948 |
| 72 | Arthropathy (HP:0003040) | 2.32262053 |
| 73 | Pulmonary embolism (HP:0002204) | 2.27073158 |
| 74 | Generalized aminoaciduria (HP:0002909) | 2.26332462 |
| 75 | Cholecystitis (HP:0001082) | 2.25967058 |
| 76 | Abnormal gallbladder physiology (HP:0012438) | 2.25967058 |
| 77 | Amyloidosis (HP:0011034) | 2.20840767 |
| 78 | Enlarged kidneys (HP:0000105) | 2.20681624 |
| 79 | Esophageal varix (HP:0002040) | 2.19778848 |
| 80 | Pancreatitis (HP:0001733) | 2.18839064 |
| 81 | Sensorimotor neuropathy (HP:0007141) | 2.16865850 |
| 82 | Vomiting (HP:0002013) | 2.16585556 |
| 83 | Late onset (HP:0003584) | 2.14594421 |
| 84 | Alkalosis (HP:0001948) | 2.12253951 |
| 85 | Brushfield spots (HP:0001088) | 2.09909405 |
| 86 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.09441727 |
| 87 | Menorrhagia (HP:0000132) | 2.09346571 |
| 88 | Abnormality of proline metabolism (HP:0010907) | 2.09252728 |
| 89 | Hydroxyprolinuria (HP:0003080) | 2.09252728 |
| 90 | Rickets (HP:0002748) | 2.04774203 |
| 91 | Opisthotonus (HP:0002179) | 2.03219644 |
| 92 | Gingival bleeding (HP:0000225) | 2.01925949 |
| 93 | Thrombophlebitis (HP:0004418) | 2.01784056 |
| 94 | Hyperphosphaturia (HP:0003109) | 2.01617407 |
| 95 | Hyperuricemia (HP:0002149) | 2.01541530 |
| 96 | Increased purine levels (HP:0004368) | 2.01541530 |
| 97 | Proximal tubulopathy (HP:0000114) | 1.99672617 |
| 98 | Hemorrhage of the eye (HP:0011885) | 1.97828369 |
| 99 | Abnormality of the gallbladder (HP:0005264) | 1.95479331 |
| 100 | Abnormal cartilage morphology (HP:0002763) | 1.95162144 |
| 101 | Neonatal hypoglycemia (HP:0001998) | 1.95152207 |
| 102 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.93565472 |
| 103 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.90473043 |
| 104 | Poikilocytosis (HP:0004447) | 1.90220605 |
| 105 | Hypophosphatemic rickets (HP:0004912) | 1.89912017 |
| 106 | Reduced antithrombin III activity (HP:0001976) | 1.84508817 |
| 107 | Retinal atrophy (HP:0001105) | 1.82402712 |
| 108 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.81486705 |
| 109 | Abnormality of urine glucose concentration (HP:0011016) | 1.80436600 |
| 110 | Glycosuria (HP:0003076) | 1.80436600 |
| 111 | Abnormality of iron homeostasis (HP:0011031) | 1.80085759 |
| 112 | Renal cortical cysts (HP:0000803) | 1.79951933 |
| 113 | Abnormality of alanine metabolism (HP:0010916) | 1.75960001 |
| 114 | Hyperalaninemia (HP:0003348) | 1.75960001 |
| 115 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.75960001 |
| 116 | Hypothermia (HP:0002045) | 1.74197441 |
| 117 | Generalized hypopigmentation of hair (HP:0011358) | 1.70105026 |
| 118 | Abnormality of vitamin metabolism (HP:0100508) | 1.66789566 |
| 119 | Joint swelling (HP:0001386) | 1.64989479 |
| 120 | Neoplasm of the liver (HP:0002896) | 1.61927721 |
| 121 | Potter facies (HP:0002009) | 1.61900705 |
| 122 | Facial shape deformation (HP:0011334) | 1.61900705 |
| 123 | Abnormal urine phosphate concentration (HP:0012599) | 1.59477296 |
| 124 | Increased serum pyruvate (HP:0003542) | 1.56213687 |
| 125 | Bifid scrotum (HP:0000048) | 1.55041306 |
| 126 | Hyperglycemia (HP:0003074) | 1.54803761 |
| 127 | Increased serum ferritin (HP:0003281) | 1.54446843 |
| 128 | Epistaxis (HP:0000421) | 1.54257319 |
| 129 | Cerebral palsy (HP:0100021) | 1.53286722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.37804256 |
| 2 | SIK1 | 4.59539544 |
| 3 | FGFR4 | 4.43475555 |
| 4 | ERN1 | 4.37251287 |
| 5 | INSRR | 2.84228300 |
| 6 | TAOK3 | 2.71651877 |
| 7 | ERBB4 | 2.63091737 |
| 8 | PKN2 | 2.52664351 |
| 9 | NLK | 2.45998773 |
| 10 | MAP4K2 | 2.45234937 |
| 11 | MUSK | 2.29156690 |
| 12 | MST1R | 2.23285593 |
| 13 | TRIB3 | 2.20295112 |
| 14 | MAP2K4 | 2.17228239 |
| 15 | CAMKK2 | 2.01731937 |
| 16 | NUAK1 | 1.90573493 |
| 17 | FLT3 | 1.86480202 |
| 18 | MAPK11 | 1.80927575 |
| 19 | LATS1 | 1.76761429 |
| 20 | PIK3CA | 1.74300951 |
| 21 | MAPKAPK3 | 1.69219650 |
| 22 | PIK3CG | 1.66646930 |
| 23 | PTK6 | 1.51179379 |
| 24 | TYK2 | 1.49887730 |
| 25 | ABL2 | 1.41479950 |
| 26 | DAPK2 | 1.41342922 |
| 27 | FRK | 1.41140027 |
| 28 | FGFR2 | 1.35169238 |
| 29 | NEK9 | 1.33287535 |
| 30 | ZAK | 1.29626207 |
| 31 | ACVR1B | 1.29517473 |
| 32 | CAMKK1 | 1.25080393 |
| 33 | KDR | 1.24198081 |
| 34 | MAP3K4 | 1.21981037 |
| 35 | MAP3K7 | 1.21872174 |
| 36 | TXK | 1.19842457 |
| 37 | PINK1 | 1.18507734 |
| 38 | SIK2 | 1.17846087 |
| 39 | STK38L | 1.16570724 |
| 40 | JAK2 | 1.14237636 |
| 41 | PRKAA2 | 1.13632146 |
| 42 | BMPR1B | 1.12995947 |
| 43 | CASK | 1.08332743 |
| 44 | ADRBK2 | 1.05864402 |
| 45 | MAP2K3 | 1.05686457 |
| 46 | NTRK3 | 1.05375026 |
| 47 | GRK6 | 1.04612945 |
| 48 | TNK2 | 1.04477715 |
| 49 | TYRO3 | 1.02582337 |
| 50 | TLK1 | 1.00762553 |
| 51 | VRK1 | 0.97315295 |
| 52 | ERBB2 | 0.95194582 |
| 53 | MAP3K10 | 0.94887087 |
| 54 | MET | 0.94727361 |
| 55 | JAK1 | 0.93354200 |
| 56 | TBK1 | 0.91967057 |
| 57 | MAPK13 | 0.91610234 |
| 58 | PRKCZ | 0.90886297 |
| 59 | EPHB1 | 0.89107999 |
| 60 | MAPK4 | 0.88563982 |
| 61 | MAP3K3 | 0.86889153 |
| 62 | TIE1 | 0.85173795 |
| 63 | BRD4 | 0.84792991 |
| 64 | FGFR1 | 0.84263247 |
| 65 | MAPK12 | 0.80276487 |
| 66 | NTRK2 | 0.78994857 |
| 67 | CAMK1D | 0.78271036 |
| 68 | EEF2K | 0.77916324 |
| 69 | DYRK1B | 0.77697008 |
| 70 | PRKG1 | 0.77401608 |
| 71 | CDK8 | 0.76868797 |
| 72 | CSNK1D | 0.76596803 |
| 73 | STK16 | 0.76056579 |
| 74 | CDK6 | 0.75679924 |
| 75 | MAP3K14 | 0.75482956 |
| 76 | RIPK1 | 0.75055548 |
| 77 | BCR | 0.74793641 |
| 78 | CDK7 | 0.74243678 |
| 79 | GSK3A | 0.73388116 |
| 80 | DYRK2 | 0.72371688 |
| 81 | PRKACG | 0.72269461 |
| 82 | MAP3K11 | 0.71512653 |
| 83 | EPHA3 | 0.70615976 |
| 84 | SGK3 | 0.70481200 |
| 85 | PRKAA1 | 0.70452457 |
| 86 | PRKACA | 0.69957939 |
| 87 | MAPK15 | 0.68554220 |
| 88 | VRK2 | 0.68066969 |
| 89 | TGFBR2 | 0.67528500 |
| 90 | PTK2 | 0.65780809 |
| 91 | BRSK2 | 0.64642329 |
| 92 | TNIK | 0.64065773 |
| 93 | WNK4 | 0.63165314 |
| 94 | BRSK1 | 0.62962424 |
| 95 | CSK | 0.62786807 |
| 96 | PDK2 | 0.62775279 |
| 97 | CAMK2G | 0.60483801 |
| 98 | MAP2K6 | 0.60273906 |
| 99 | PDPK1 | 0.55425380 |
| 100 | FGFR3 | 0.55390087 |
| 101 | PDK4 | 0.53701406 |
| 102 | PDK3 | 0.53701406 |
| 103 | IRAK3 | 0.53631107 |
| 104 | SGK2 | 0.52635840 |
| 105 | ITK | 0.52119021 |
| 106 | MAPK7 | 0.51733517 |
| 107 | SGK223 | 0.51413793 |
| 108 | SGK494 | 0.51413793 |
| 109 | WNK3 | 0.49267105 |
| 110 | CSF1R | 0.48719416 |
| 111 | RET | 0.46599430 |
| 112 | MAP2K7 | 0.46274478 |
| 113 | LCK | 0.45673707 |
| 114 | MAP2K1 | 0.45489310 |
| 115 | CSNK1G1 | 0.44675055 |
| 116 | PRKCQ | 0.44073894 |
| 117 | CSNK2A1 | 0.43991461 |
| 118 | TAOK2 | 0.43315149 |
| 119 | IGF1R | 0.42916467 |
| 120 | MAP4K1 | 0.42131423 |
| 121 | MTOR | 0.41829318 |
| 122 | EPHA4 | 0.41437022 |
| 123 | SGK1 | 0.40990294 |
| 124 | PLK3 | 0.40775867 |
| 125 | PRKCB | 0.40635661 |
| 126 | CSNK2A2 | 0.39934020 |
| 127 | CSNK1A1 | 0.39721881 |
| 128 | PASK | 0.39093711 |
| 129 | ICK | 0.38782814 |
| 130 | IKBKE | 0.38450924 |
| 131 | CSNK1E | 0.37965217 |
| 132 | MAP3K5 | 0.37462180 |
| 133 | AKT3 | 0.37403128 |
| 134 | CDK4 | 0.37093954 |
| 135 | LIMK1 | 0.37002032 |
| 136 | LATS2 | 0.36846037 |
| 137 | PRKCE | 0.36135935 |
| 138 | HIPK2 | 0.36055871 |
| 139 | PRKCG | 0.35629668 |
| 140 | GRK1 | 0.34582887 |
| 141 | PDK1 | 0.33886934 |
| 142 | BMX | 0.33375231 |
| 143 | CAMK1G | 0.31222913 |
| 144 | PDGFRA | 0.30776048 |
| 145 | CAMK4 | 0.29408381 |
| 146 | MAP2K2 | 0.29164185 |
| 147 | IRAK2 | 0.29097743 |
| 148 | EGFR | 0.29097241 |
| 149 | MAP3K6 | 0.28301468 |
| 150 | OXSR1 | 0.27765172 |
| 151 | PKN1 | 0.27007486 |
| 152 | MAP3K13 | 0.26939369 |
| 153 | PAK3 | 0.26880146 |
| 154 | IRAK1 | 0.25771841 |
| 155 | PRKCA | 0.23919364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.37255380 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.61267387 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.38829684 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.35453341 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.05103996 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.70016075 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68523419 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.66699636 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.62535788 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.53017236 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.47920803 |
| 12 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.47229545 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.29467420 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.23748746 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.09270999 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.08067806 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03616685 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.89233997 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87260090 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87147043 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86968684 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.86542431 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84350407 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75284785 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75041873 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71720543 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.69590193 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66739616 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64791419 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64567568 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.64451517 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.63746461 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57813818 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53800242 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.51316840 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.43275693 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.42014428 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39602489 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38566919 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31302012 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29785175 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28987275 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24078205 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.22129842 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18449228 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.17895299 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16804426 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.15649857 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.14888304 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07013264 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01939585 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00544917 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97582947 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94201926 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93578175 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93547738 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92217462 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.85037589 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82269650 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73958462 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73316658 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73145688 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.68296492 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.60990702 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57715671 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54317547 |
| 67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45961070 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.31058892 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.29541867 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27119071 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25755641 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25063299 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.24616292 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23590641 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.21527388 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.21348536 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19640466 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18473310 |
| 79 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.15539552 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14387309 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10005652 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.04794917 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04152003 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | -0.2271939 |
| 85 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2217861 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2199704 |
| 87 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1952052 |
| 88 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1887507 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1861524 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | -0.1816495 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1783118 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | -0.1768349 |
| 93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.1739153 |
| 94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1738768 |
| 95 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1731769 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1607379 |
| 97 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1583610 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1489286 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1444794 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1394438 |
| 101 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1216035 |
| 102 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1106102 |
| 103 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1017597 |
| 104 | Protein export_Homo sapiens_hsa03060 | -0.0908290 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0892314 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0840151 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0775908 |
| 108 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0739071 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0524362 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0428212 |
| 111 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0266051 |
| 112 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0253075 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | -0.0227878 |

